Investigational Procedure

PROCEDURE4 trials

Sponsors

Sanofi, Sanofi Pasteur, a Sanofi Company

Conditions

Epstein-Barr Virus (EBV)Gaucher DiseaseHealthy VolunteersPeriodontal DiseaseType 1 Diabetes

Unknown Phase

Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States (Project Searchlight)

CompletedNCT05908656

SanofiGaucher Disease

Start: 2024-04-02End: 2024-08-26Updated: 2024-11-19

Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age

CompletedNCT06582056

Sanofi Pasteur, a Sanofi CompanyPeriodontal Disease

Start: 2024-10-09End: 2025-09-30Updated: 2025-11-28

Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)

RecruitingNCT07038473

SanofiType 1 Diabetes

Start: 2025-12-17End: 2026-12-25Target: 3500Updated: 2026-08-19

A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years

Active, not recruitingNCT07536048

Sanofi Pasteur, a Sanofi CompanyEpstein-Barr Virus (EBV), Healthy Volunteers

Start: 2026-04-20End: 2027-05-14Target: 100Updated: 2026-06-11